Výsledky vyhledávání - "Pavan Maria HP"

Akademický článek

Retreatment of hepatitis C patients with pegylated interferon combined with ribavirin in non-responders to interferon plus ribavirin. Is it different in real life?

Autor: Gonçales Neiva SL, Pavan Maria HP, Tozzo Raquel, Gonçales Eduardo SL, Angerami Adriana FCF, Vigani Aline G, Moma Camila A, Gonçales Fernando L

Publikováno v: BMC Infectious Diseases, Vol 10, Iss 1, p 212 (2010)

Abstract Background More than 50% of hepatitis C viruses (HCV)-infected patients do not respond to the classical Interferon (IFN)/Ribavirin (RBV) combination therapy. The aim of this study was to evaluate the efficacy of retreatment with Peg-Interfer

Externí odkaz: https://doaj.org/article/b7dbf04642bc42b492f353ec9645bb42

Zobrazit plný text záznamu

Extended treatment with interferon and ribavirin in a hemodialysis patient with chronic hepatitis C

Autor: Vigani, Aline Gonzalez, Pavan, Maria HP, Tozzo, Raquel, Gonçales, Eduardo SL, Lazarini, Maria SK, Oliveira, Alexandre Macedo de, Gonçales Jr, Fernando L

Publikováno v: Brazilian Journal of Infectious Diseases v.14 n.2 2010
Brazilian Journal of Infectious Diseases
Brazilian Society of Infectious Diseases (BSID)
instacron:BSID
Brazilian Journal of Infectious Diseases, Volume: 14, Issue: 2, Pages: 193-196, Published: APR 2010

Hemodialysis patient with chronic HCV infection,who was started on monotherapy with interferon.Qualitative HCV RNA remained positive at 12 weeks of treatment; ribavirin was associated. HCV RNA was negative at week 24 and treatment was extended to 72

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::0064c12986afd2621705ef2ee7da240d
http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1413-86702010000200016

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání